OBJETIVO: Avaliar as alterações topográficas da córnea após a realização de vitrectomia via pars plana 20-gauge associada à introflexão escleral para o tratamento do descolamento de retina regmatogênico. MÉTODOS: Vinte e cinco pacientes com descolamento de retina regmatogênico foram incluídos neste estudo. Vitrectomia via pars plana 20-gauge associada à introflexão escleral foi realizada em todos os pacientes. O exame de topografia de córnea computadorizada de cada paciente foi realizado antes da cirurgia e ao sétimo dia, trigésimo dia e três […]

PURPOSE: To evaluate the changes in corneal topography after 20-gauge pars plana vitrectomy associated with scleral buckling for the repair of rhegmatogenous retinal detachment. METHODS: Twenty-five eyes of 25 patients with rhegmatogenous retinal detachment were included in this study. 20-gauge pars plana vitrectomy associated with scleral buckling was performed in all patients. The corneal topography of each was measured before surgery and one week, one month, and three months after surgery by computer-assisted videokeratoscopy. RESULTS: A statistically significant central corneal […]

OBJETIVO: Avaliar o efeito no pré-operatório da injecao intravítrea de bevacizumab (IVB) ou triancinolona (IVT) sobre a taxa de hemorragia precoce pos-vitrectomia na retinopatia diabética proliferativa. MÉTODOS: Os olhos foram distribuídos em três grupos: IVB – 1,25 mg bevacizumab, IVT – 4,0 mg de triancinolona e o grupo controle – simulação da injeção. O objetivo primário foi a avaliação da incidência da hemorragia precoce pós-vitrectomia. Os objetivos secundários incluíram mudanças na acuidade visual corrigida e eventos adversos relacionados à injeção. […]

PURPOSE: To evaluate the effect of preoperative intravitreal bevacizumab (IVB) or triamcinolone (IVT) on the rate of early postvitrectomy hemorrhage in proliferative diabetic retinopathy (PDR). METHODS: Eligible eyes were assigned randomly to 1 of 3 groups: the IVB group received 1.25 mg bevacizumab, the IVT group received 4,0mg triamcinolone and the control group underwent a sham procedure. The primary outcome measure was the incidence of early postvitrectomy hemorrhage. Secondary outcome measures included changes in visual acuity (BCVA) and adverse events. […]

PURPOSE: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation. METHODS: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near (UCNVA) and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients […]

OBJETIVO: Observar a eficácia da fluoresceína sódica intravenosa, na visibilidade do vítreo, durante a cirurgia de vitrectomia nos pacientes com retinopatia diabética. MÉTODOS: Quatorze casos consecutivos de cirurgia vitreorretiniana para hemorragia vítrea e descolamento tracional da retina secundário à retinopatia diabética, foram submetidos à injeção de fluoresceína intravenosa a 20%, 1 hora antes da cirurgia.As imagens de todos os passos das cirurgias foram gravadas. RESULTADOS: A fluoresceína corou de verde o vítreo periférico, base vítrea, hialóide posterior melhorando a visibilidade […]

OBJECTIVE: To observe the effectiveness of intravenous sodium fluorescein visibility in the vitreous during vitrectomy surgery in patients with diabetic retinopathy. METHODS: Fourteen consecutive cases of vitreoretinal surgery for vitreous hemorrhage and tractional retinal detachment secondary to diabetic retinopathy underwent intravenous injection of sodium fluorescein to 20% 1 hour before the surgery. The images of the steps of the surgeries were recorded. RESULTS: The sodium fluorescein stained green from the vitreous peripheral, vitreous base, posterior hyaloid, further improving visibility to […]